The FDA and NIH recently announced plans to phase out animal testing requirements for some therapies. While organoid and AI ...

Although still in its infancy, this technology has already shown remarkable effectiveness in detecting and treating cancer, ...

From easing clinician workloads to enabling faster, smarter diagnoses, these practical AI tools are transforming healthcare ...

Lantern Pharma's Q1 2025 earnings reveal clinical progress, AI commercialization plans, and financial discipline.

The increasing incidence of infectious and chronic illnesses is boosting the need for early and precise diagnosis, with AI playing a crucial role by ...

The annual analysis documented approvals of 18 new personalized medicines in 2024, important regulatory milestones and establishment of the Center fo ...

OpenAI's doomsday bunker plan, the "potential benefits" of propaganda bots, plus the best fake books you can't read this ...

Stuart J. Schnitt, MD, discussed how AI enhances cancer diagnoses and the need for professional oversight, ethical clarity, and equitable adoption.

The FDA has said it intends to reduce ... The regulator has published a roadmap (PDF) describing its plan to accelerate the validation and adoption of human-relevant NAMs and said it will now ...

Monogram Technologies Inc (MGRM) secures FDA clearance for its TKA system, while navigating competitive pressures and planning a strategic rollout.

Microsoft launches Discovery platform that uses agentic AI to compress years of scientific research into days, transforming R ...